Reviewing Select Medical (SEM) and Diplomat Pharmacy (DPLO)

Select Medical (NYSE: SEM) and Diplomat Pharmacy (NYSE:DPLO) are both medical companies, but which is the better investment? We will compare the two companies based on the strength of their earnings, valuation, institutional ownership, risk, profitability, analyst recommendations and dividends.

Profitability

This table compares Select Medical and Diplomat Pharmacy’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Select Medical 2.21% 11.44% 2.03%
Diplomat Pharmacy 0.18% 8.30% 4.70%

Institutional & Insider Ownership

77.9% of Select Medical shares are owned by institutional investors. Comparatively, 72.5% of Diplomat Pharmacy shares are owned by institutional investors. 19.9% of Select Medical shares are owned by company insiders. Comparatively, 30.2% of Diplomat Pharmacy shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Earnings and Valuation

This table compares Select Medical and Diplomat Pharmacy’s revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Select Medical $4.29 billion 0.55 $115.41 million $0.73 24.18
Diplomat Pharmacy $4.41 billion 0.29 $28.27 million $0.10 187.50

Select Medical has higher earnings, but lower revenue than Diplomat Pharmacy. Select Medical is trading at a lower price-to-earnings ratio than Diplomat Pharmacy, indicating that it is currently the more affordable of the two stocks.

Risk and Volatility

Select Medical has a beta of 1.35, suggesting that its share price is 35% more volatile than the S&P 500. Comparatively, Diplomat Pharmacy has a beta of 0.61, suggesting that its share price is 39% less volatile than the S&P 500.

Analyst Recommendations

This is a summary of current ratings and price targets for Select Medical and Diplomat Pharmacy, as provided by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Select Medical 1 1 4 0 2.50
Diplomat Pharmacy 0 5 3 0 2.38

Select Medical presently has a consensus price target of $19.60, indicating a potential upside of 11.05%. Diplomat Pharmacy has a consensus price target of $19.94, indicating a potential upside of 6.33%. Given Select Medical’s stronger consensus rating and higher possible upside, research analysts clearly believe Select Medical is more favorable than Diplomat Pharmacy.

Summary

Select Medical beats Diplomat Pharmacy on 10 of the 14 factors compared between the two stocks.

About Select Medical

Select Medical Holdings Corporation is an operator of specialty hospitals, outpatient rehabilitation clinics and occupational medicine centers in the United States. The Company’s segments include specialty hospitals, outpatient rehabilitation, Concentra and Other. The specialty hospitals segment consists of hospitals designed to serve the needs of long term acute patients and hospitals designed to serve patients that require intensive medical rehabilitation care. The outpatient rehabilitation segment consists of clinics that provide physical, occupational, and speech rehabilitation services. The Concentra segment consists of medical centers and contract services provided at employer worksites and Department of Veterans Affairs community-based outpatient clinics (CBOCs) that deliver occupational medicine, physical therapy, veteran’s healthcare, and consumer health services. As of December 31, 2016, the Company had operations in 46 states and the District of Columbia.

About Diplomat Pharmacy

Diplomat Pharmacy, Inc. (Diplomat) operates a specialty pharmacy business, which stocks, dispenses and distributes prescriptions for various biotechnology and specialty pharmaceutical manufacturers. The Company operates through specialty pharmacy services segment. The Company’s primary focus is on medication management programs for individuals with chronic diseases, including oncology, immunology, hepatitis, multiple sclerosis, specialty infusion therapy, and various other serious and/or long-term conditions. The Company provides specialty pharmacy support services to a national network of retailers and independent pharmacy groups, hospitals and health systems. The Company offers various services, such as specialty drug dispensing, retail specialty services, hospital and health system services, and hub services. The Company’s patient care system is used to coordinate and track patient adherence and safety.

Receive News & Ratings for Select Medical Holdings Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Select Medical Holdings Corporation and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply